Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2025)

Incannex Healthcare's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $349.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1889.75% year-over-year to $349.5 million; the TTM value through Dec 2025 reached $349.5 million, up 1889.75%, while the annual FY2025 figure was $34.5 million, 113.15% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $349.5 million at Incannex Healthcare, up from $310.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $349.5 million in Q4 2025 and bottomed at $15.9 million in Q3 2023.
  • The 3-year median for Shares Outstanding (Weighted Average) is $17.6 million (2024), against an average of $81.1 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) increased 10.65% in 2024 before it soared 1889.75% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $15.9 million in 2023, then grew by 10.65% to $17.6 million in 2024, then skyrocketed by 1889.75% to $349.5 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Shares Outstanding (Weighted Average) are $349.5 million (Q4 2025), $310.3 million (Q3 2025), and $34.5 million (Q2 2025).